The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Open accessAbstract
In both Drosophila and mammalian systems, the Hippo pathway plays an important role in controlling organ size, mainly through its ability to regulate cell proliferation and apoptosis. The key component in the Hippo pathway is the Yes-associated protein YAP1, which localizes in nucleus, functions as a transcriptional coactivator, and regulates the expression of several proliferation- and apoptosis-related genes. The Hippo pathway negatively regulates YAP1 transcriptional activity by modulating its nuclear-cytoplasmic localization in a phosphorylation-dependent manner. Here, we describe the identification of several new PY motif-containing proteins, including angiomotin-like protein 1 (AMOTL1) and 2 (AMOTL2), as YAP1-associated proteins. We demonstrate that AMOTL1 and AMOTL2 can regulate YAP1 cytoplasm-to-nucleus translocation through direct protein-protein interaction, which can occur independent of YAP1 phosphorylation status. Moreover, down-regulation of AMOTL2 in MCF10A cells promotes epithelial-mesenchymal transition, a phenotype that is also observed in MCF10A cells with YAP1 overexpression. Together, these data support a new mechanism for YAP1 regulation, which is mediated via its direct interactions with angiomotin-like proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Self-citationA coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis
Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 976
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C.-X., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 885
Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., & Halder, G. (2006) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 767
Hippo signaling in organ size control
Pan, D. (2007) · Genes & Development · doi:10.1101/gad.1536007 · Cited by 647
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
The Ste20 group kinases as regulators of MAP kinase cascades
Dan, I., Watanabe, N. M., & Kusumi, A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01980-8 · Cited by 627
Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats
Lai, Z.-C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L.-L., & Li, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.036 · Cited by 568
The Hippo–YAP pathway: new connections between regulation of organ size and cancer
Zhao, B., Lei, Q.-Y., & Guan, K.-L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.001 · Cited by 455
Goulev, Y., Fauny, J. D., Gonzalez-Marti, B., Flagiello, D., Silber, J., & Zider, A. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.034 · Cited by 452
Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
Delineation of a Fat tumor suppressor pathway
Cho, E., Feng, Y., Rauskolb, C., Maitra, S., Fehon, R., & Irvine, K. D. (2006) · Nature Genetics · doi:10.1038/ng1887 · Cited by 432
Thompson, B. J., & Cohen, S. M. (2006) · Cell · doi:10.1016/j.cell.2006.07.013 · Cited by 398
Troyanovsky, B., Levchenko, T., Månsson, G., Matvijenko, O., & Holmgren, L. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1247 · Cited by 383
Fat Cadherin Modulates Organ Size in Drosophila via the Salvador/Warts/Hippo Signaling Pathway
Bennett, F. C., & Harvey, K. F. (2006) · Current Biology · doi:10.1016/j.cub.2006.09.045 · Cited by 314
Membrane organization and tumorigenesis—the NF2 tumor suppressor, Merlin
McClatchey, A. I., & Giovannini, M. (2005) · Genes & Development · doi:10.1101/gad.1335605 · Cited by 286
The bantam MicroRNA Is a Target of the Hippo Tumor-Suppressor Pathway
Nolo, R., Morrison, C. M., Tao, C., Zhang, X., & Halder, G. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.057 · Cited by 265
Ren, F., Zhang, L., & Jiang, J. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2009.10.046 · Cited by 181
Angiomotin Regulates Endothelial Cell-Cell Junctions and Cell Motility
Bratt, A., Birot, O., Sinha, I., Veitonmäki, N., Aase, K., Ernkvist, M., & Holmgren, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503915200 · Cited by 175
Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains
Bratt, A., Wilson, W. J., Troyanovsky, B., Aase, K., Kessler, R., Meir, E. G. V., & Holmgren, L. (2002) · Gene · doi:10.1016/s0378-1119(02)00928-9 · Cited by 161
Zheng, Y., Vertuani, S., Nyström, S., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.195156 · Cited by 117
Shedding light on Merlin's wizardry
Okada, T., You, L., & Giancotti, F. G. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.03.006 · Cited by 112
Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation
Huang, H.-Z., Lu, F.-I., Jia, S.-J., Meng, S., Cao, Y., Wang, Y.-Q., Ma, W., Yin, K., Wen, Z.-L., Peng, J., et al. (2007) · Development · doi:10.1242/dev.02782 · Cited by 69
Gagné, V., Moreau, J., Plourde, M. B., Lapointe, M., Lord, M., Gagnon, É., & Fernandes, M. (2009) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20405 · Cited by 50
Cited by
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R., & Halder, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 881
Metadata
- Authors
- Wang, W., Huang, J., & Chen, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 286
- Issue
- 6
- Pages
- 4364-4370
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2078377283
- Cited by
- 269
- References
- 28
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.